370 related articles for article (PubMed ID: 8051983)
21. Therapeutic advantage of recombinant human plasminogen activator in endocarditis: evidence from experiments in rabbits.
Meyer MW; Witt AR; Krishnan LK; Yokota M; Roszkowski MJ; Rudney JD; Herzberg MC
Thromb Haemost; 1995 Apr; 73(4):680-2. PubMed ID: 7495078
[TBL] [Abstract][Full Text] [Related]
22. Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitis.
Lowy FD; Neuhaus EG; Chang DS; Steigbigel NH
Antimicrob Agents Chemother; 1983 Jan; 23(1):67-73. PubMed ID: 6830210
[TBL] [Abstract][Full Text] [Related]
23. [Therapy and prevention of infectious endocarditis].
Horstkotte D; Rosin H
Schweiz Med Wochenschr; 1984 Nov; 114(45):1575-86. PubMed ID: 6515354
[TBL] [Abstract][Full Text] [Related]
24. Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G.
Savitch CB; Barry AL; Hoeprich PD
Arch Intern Med; 1978 Jun; 138(6):931-4. PubMed ID: 246729
[TBL] [Abstract][Full Text] [Related]
25. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
Gavaldà J; Pahissa A; Almirante B; Laguarda M; Crespo E; Pou L; Fernández F
Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723
[TBL] [Abstract][Full Text] [Related]
26. Bacterial endocarditis due to penicillin-resistant Streptococcus viridans.
McCarthy VP; Cho CT; Diehl AM; Ramsey BW
Clin Pediatr (Phila); 1979 May; 18(5):263-6. PubMed ID: 109241
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis.
Brennan RO; Durack DT
Antimicrob Agents Chemother; 1983 Feb; 23(2):273-7. PubMed ID: 6838188
[TBL] [Abstract][Full Text] [Related]
28. Experimental endocarditis caused by Streptococcus sanguis: single and combined antibiotic therapy.
Vicente MV; Olay T; Rodríguez A
Antimicrob Agents Chemother; 1981 Jul; 20(1):10-4. PubMed ID: 7283409
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
Chambers HF; Xiang Q; Liu ; Chow LL; Hackbarth C
Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of antimicrobial agents in the rabbit model of endocarditis.
Sande MA
Rev Infect Dis; 1981; 3 suppl():S240-9. PubMed ID: 7342288
[TBL] [Abstract][Full Text] [Related]
32. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals.
Wilson WR; Zak O; Sande MA
J Infect Dis; 1985 Jun; 151(6):1028-33. PubMed ID: 3846608
[TBL] [Abstract][Full Text] [Related]
33. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
34. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis.
Wright AJ; Wilson WR; Matsumoto JY; Washington JA; Geraci JE
Antimicrob Agents Chemother; 1982 Dec; 22(6):972-5. PubMed ID: 6818902
[TBL] [Abstract][Full Text] [Related]
35. The heterogeneity of Streptococcus viridans: therapeutic considerations in infective endocarditis.
Fisher J; Levene DL
Can Med Assoc J; 1975 May; 112(10):1217-9. PubMed ID: 1125890
[TBL] [Abstract][Full Text] [Related]
36. Tolerance and efficacy of parenterally administered penicillin-streptomycin and orally administered amoxicillin or penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.
Pujadas R; Escriva E; Jane J; Argimon J; Fernandez F; Fava P; Galera M; Garau J
Antimicrob Agents Chemother; 1990 Feb; 34(2):321-5. PubMed ID: 2109579
[TBL] [Abstract][Full Text] [Related]
37. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
Knudsen JD
Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
[TBL] [Abstract][Full Text] [Related]
38. Effect of penicillin on the adherence of Streptococcus sanguis in vitro and in the rabbit model of endocarditis.
Lowy FD; Chang DS; Neuhaus EG; Horne DS; Tomasz A; Steigbigel NH
J Clin Invest; 1983 Mar; 71(3):668-75. PubMed ID: 6826729
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis.
Sullam PM; Täuber MG; Hackbarth CJ; Sande MA
Antimicrob Agents Chemother; 1985 Jan; 27(1):135-6. PubMed ID: 3157344
[TBL] [Abstract][Full Text] [Related]
40. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Galetto DW; Boscia JA; Kobasa WD; Kaye D
J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
